Exchange: NASDAQ·Updated 07:58 PM EST

BNGO News

News
all
press releases
Sarepta Therapeutics (SRPT) Q3 Earnings Lag Estimates
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -64.87% and +9.43%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Sarepta Therapeutics (SRPT) Q3 Earnings Lag Estimates
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -64.87% and +9.43%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Bionano Genomics is surging Tuesday as investors weigh its growth strategy and favorable milestones for its genome mapping technology.read more...
Benzinga
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Bionano Genomics (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Bionano Genomics (BNGO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Zacks
Bionano Genomics (BNGO) delivered earnings and revenue surprises of +6.17% and +2.88%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Arvinas (ARVN) delivered earnings and revenue surprises of +5.01% and -0.74%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Lexicon (LXRX) delivered earnings and revenue surprises of +100.00% and +141.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Bionano Genomics stock soared on Monday as investors anticipated the company's Q4 earnings report.read more...
Benzinga

Advertisement|Remove ads.